Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Infectious Diseases

• Publication date

  1988-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INFDIS/157.6.1150PMID 2897398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid

  1987cited by this paper
• Construction of a penicillin-tolerant laboratory mutant ofStaphylococcus aureus

  1986cited by this paper
• Beta-lactam-specific resistant mutants of Staphylococcus aureus

  1986cited by this paper
• Alterations in penicillin-binding proteins of clinical and laboratory isolates of pathogenic Streptococcus pneumoniae with low levels of penicillin resistance.

  1986cited by this paper
• A rapid procedure to detect the autolysin phenotype in Streptococcus pneumoniae

  1985cited by this paper
• Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae.

  1985cited by this paper
• Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects.

  1981cited by this paper
• Effect of storage and changes in bacterial growth phase and antibiotic concentrations on antimicrobial tolerance in Staphylococcus aureus

  1980cited by this paper
• In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae

  1980cited by this paper
• Escherichia coli Mutants Tolerant to Beta-Lactam Antibiotics

  1979cited by this paper
• Lipoteichoic acid: a specific inhibitor of autolysin activity in Pneumococcus.

  1975cited by this paper
• Mechanism of action of penicillin: triggering of the pneumococcal autolytic enzyme by inhibitors of cell wall synthesis.

  1975cited by this paper
• Marker discrimination in transformation and mutation of pneumococcus.

  1973cited by this paper
• Model for the Mechanism Controlling the Expression of Competent State in Pneumococcus Cultures

  1966cited by this paper
• A procedure for the isolation of deoxyribonucleic acid from micro-organisms

  1961cited by this paper
• A study of the genetic material determining an enzyme in Pneumococcus.

  1960cited by this paper

• A long non-coding RNA regulates triazole antifungal susceptibility and virulence in Aspergillus fumigatus

  2025cites this paper
• Structure, Function, and Regulation of LytA: The N-Acetylmuramoyl-l-alanine Amidase Driving the “Suicidal Tendencies” of Streptococcus pneumoniae—A Review

  2025cites this paper
• When does antimicrobial resistance increase bacterial fitness? Effects of dosing, social interactions, and frequency dependence on the benefits of AmpC β-lactamases in broth, biofilms, and a gut infection model

  2024cites this paper
• Combatting persister cells: The daunting task in post-antibiotics era

  2023cites this paper
• Gaps in the wall: understanding cell wall biology to tackle amoxicillin resistance in Streptococcus pneumoniae.

  2023cites this paper
• Increased Expression of Efflux Pump norA Drives the Rapid Evolutionary Trajectory from Tolerance to Resistance against Ciprofloxacin in Staphylococcus aureus

  2022cites this paper
• Rapid resistance development to three antistaphylococcal therapies in antibiotic-tolerant staphylococcus aureus bacteremia

  2021cites this paper
• Targeting Superoxide Dismutase Confers Enhanced Reactive Oxygen Species-Mediated Eradication of Polymyxin B-Induced Acinetobacter baumannii Persisters

  2021cites this paper
• Ecology and evolution of antibiotic persistence.

  2021cites this paper
• Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases

  2020cites this paper
• Strategies to Combat Persistent Infectious Diseases

  2019cites this paper
• Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates

  2019cites this paper
• General Mechanisms Leading to Persister Formation and Awakening.

  2019cites this paper
• Antibiotics: Combatting Tolerance To Stop Resistance

  2019cites this paper
• Evolution Under Antibiotic Treatments: Interplay Between Antibiotic Persistence, Tolerance, and Resistance

  2019cites this paper
• Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials

  2016cites this paper
• LytA, Major Autolysin of Streptococcus pneumoniae, Requires Access to Nascent Peptidoglycan

  2012cites this paper
• Vancomycin tolerance in clinical and laboratory Streptococcus pneumoniae isolates depends on reduced enzyme activity of the major LytA autolysin or cooperation between CiaH histidine kinase and capsular polysaccharide

  2010cites this paper
• Lysis Molecular Control of Bacterial Death and

  2008cites this paper
• Molecular Control of Bacterial Death and Lysis

  2008cites this paper
• Amoxicillin Is Effective against Penicillin-Resistant Streptococcus pneumoniae Strains in a Mouse Pneumonia Model Simulating Human Pharmacokinetics

  2006cites this paper
• Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.

  2006cites this paper
• Pneumococcal Resistance to Antibioticst PREVALENCE AND DISTRIBUTION OF RESISTANT PNEUMOCOCCI IMPACT OF RESISTANCE ON CLINICAL MOLECULAR EVOLUTION OF PENICILLIN RESISTANCE

  2003cites this paper
• Chapter 17 – Initiation of Bacterial Killing by Two-Component Sensing of a “Death Peptide”: Development of Antibiotic Tolerance in Streptococcus pneumoniae

  2003cites this paper
• Vancomycin Tolerance Induced by Erythromycin but Not by Loss of vncRS, vex3, or pep27 Function in Streptococcus pneumoniae

  2002cites this paper
• Importance of dose and duration of beta-lactam therapy in nasopharyngeal colonization with resistant pneumococci.

  2002cites this paper
• Vancomycin-tolerant Streptococcus pneumoniae and its clinical significance.

  2001cites this paper
• Low-level antibacterial resistance: a gateway to clinical resistance.

  2001cites this paper
• Penicillin-Resistant Streptococcus pneumoniae in Metropolitan New York Hospitals: Case Control Study and Molecular Typing of Resistant Isolates

  2001cites this paper
• Deregulation of the Arginine Deiminase (arc) Operon in Penicillin-Tolerant Mutants ofStreptococcus gordonii

  2000cites this paper
• Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin.

  2000cites this paper
• β-Lactam-Resistant Streptococcus pneumoniae: Epidemiology and Evolutionary Mechanism

  1999cites this paper
• Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae.

  1999cites this paper
• Why have group A streptococci remained susceptible to penicillin? Report on a symposium.

  1998cites this paper
• Austrian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae 1994-96.

  1998cites this paper
• In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.

  1998cites this paper
• Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

  1998cites this paper
• In Vitro Activity of Sanfetrinem and Affinity for the Penicillin-Binding Proteins of Streptococcus pneumoniae

  1998cites this paper
• Penicillin-Resistant Streptococcus pneumoniae in Argentina: Frequent Occurrence of an Internationally Spread Serotype 14 Clone

  1998cites this paper
• Characterization of Lactobacillus bacteriophage LL-H genes and proteins having biotechnological interest

  1998cites this paper
• Mosaic genes and their role in penicillin‐resistant Streptococcus pneumoniae (minireview)

  1998cites this paper
• Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.

  1998cites this paper
• Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media.

  1997cites this paper
• The antibiotic selective process: concentration-specific amplification of low-level resistant populations.

  1997cites this paper
• Effets comparés de la pénicilline, de l'amoxicilline et du céfotaxime in vitro sur Streptococcus pneumoniae

  1997cites this paper
• Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis

  1997cites this paper
• Penicillin dosing for pneumococcal pneumonia.

  1997cites this paper
• Antibiotic resistance in Streptococcus pneumoniae.

  1997cites this paper
• Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii.

  1997cites this paper
• Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics

  1996cites this paper
• R Hakenbeck beta-lactam antibiotics . resistance determinants for different classes of Streptococcus pneumoniae are primary Penicillin-binding proteins 2 b and 2 x of

  1996cites this paper
• Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains

  1996cites this paper
• Arguments microbiologiques pour le choix du traitement optimal des méningites à pneumocoque résistant à la pénicilline

  1996cites this paper
• In vitro selection of Streptococcus pheumoniae strains with decreased susceptibility to beta-lactams and macrolides

  1996cites this paper
• [Antibiotic resistance in pneumococci].

  1996cites this paper
• Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA

  1995cites this paper
• Beta-Lactam Antibiotics: Is Continuous Infusion The Preferred Method of Administration?

  1995cites this paper
• Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany, 1992-1994.

  1995cites this paper
• [Bacterial resistance to antibiotics].

  1995cites this paper
• Penicillin-Resistant and Multidrug-Resistant Streptococcus pneumoniae in a Pediatrie Hospital in Zagreb, Croatia

  1995cites this paper
• Prevalence and resistance mechanisms of common bacterial respiratory pathogens.

  1994cites this paper
• Bases molculaires de la rsistance du pneumocoque aux -lactamines

  1994cites this paper
• Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic.

  1993cites this paper
• Mode of Action of Penicillin in Pneumococci: From Inhibition of Cellular Targets to Bacterial Death

  1993cites this paper
• SELECTING THE ANTIBIOTIC

  1993cites this paper
• Infections due to antibiotic-resistant gram-positive cocci

  1993cites this paper
• Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States

  1992cites this paper
• Bacteriophage lysis: mechanism and regulation

  1992cites this paper
• Continuous infusion of beta-lactam antibiotics

  1992cites this paper
• A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone

  1992cites this paper
• Pharmacocintique et pouvoir bactricide du cfuroxime axtil : modle in vitro/ex vivo

  1991cites this paper
• Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary.

  1991cites this paper
• Mechanism of killing of pneumococci by lysozyme.

  1991cites this paper
• Penicillin-resistant pneumococci.

  1991cites this paper
• Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989.

  1991cites this paper
• Two bactericidal targets for penicillin in pneumococci: autolysis-dependent and autolysis-independent killing mechanisms

  1990cites this paper
• Autolysins are direct involved in the bactericidal effect caused by penicillin in wild type and in tolerant pneumococci.

  1990cites this paper
• Pneumococcal resistance to antibiotics

  1990cites this paper
• Inhibition of the binding of penicillin to the pneumococcal penicillin-binding proteins (PBPs) by exogenous cell wall peptides.

  1989cites this paper
• Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci.

  1989cites this paper
• Multiple Penicillin Binding Protein Profiles in Penicillin Resistant Pneumococci: Evidence for the Clonal Nature of Resistance Among Clinical Isolates

  1989cites this paper
• Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits

  1989cites this paper
• Lytic and bactericidal activity of FCE 22101.

  1989cites this paper
• Microbiological and clinical significance of a new property of defective lysis in clinical strains of pneumococci.

  1988cites this paper